This country profile provides an overview of the Congo’s progress in reaching those in need of mass NTD treatment based on 2017 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Download country profiles
Priorities for progress in Congo
- Congo is encouraged to continue working to build its national preventive chemotherapy programme for NTDs.
- It should aim to provide a systematically high annual coverage of all intervention components, in all risk groups, as recommended by WHO.
- Further, Congo should carry out mapping for the elimination of river blindness.
- Support the Expanded Special Project for Elimination of Neglected Tropical Diseases (ESPEN) established by WHO AFRO region for the elimination of these five diseases.
Treatment coverage increased from 12% in 2016 to 14% in 2017.
Congo does not require mass treatment for blinding trachoma.
Treatment coverage increased 3% in 2016 to 38% in 2017.
Treatment coverage increased from 25% in 2016 to 53% in 2017.
Treatment coverage decreased from 79% in 2016 to 29% in 2017.